InsiderTrades

Form 4 for AXGN Axogen, Inc.

Accepted 2026-06-23 16:37:20 ET · period of report 2026-06-19 · accession 0000805928-26-000080 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2026-06-23 16:37 2026-06-19 AXGN Levine Alan M Dir M - OptEx $0.00 +14.2K 50.9K +39% $0
D 2026-06-23 16:37 2026-06-19 AXGN Levine Alan M Dir M - OptEx $0.00 +14.2K 0 New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-06-19 M A 14,150 $0.00 50,893 D — — (F1) This reflects the number of restricted stock units that vested June 19, 2026.
2 Derivative Restricted Stock Units 2026-06-19 M A 14,150 $0.00 0 D — · — to — 14,150 Common Stock (F2) Each restricted stock unit represents a contingent right to receive one share of Axogen, Inc. common stock. (F3) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date. (F3) Annual equity grant for service as Director on the Axogen, Inc. Board of Directors. The number of shares pursuant to the equity grant is based on a $150,000 valuation as of the grant date and vests on June 19, 2026, the one-year anniversary of the grant date.